Oyster Point Pharma

Oyster Point Pharma company information, Employees & Contact Information

Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.

Company Details

Employees
50
Founded
-
Address
202 Carnegie Ctr Ste 106, Princeton,new Jersey 08540,united States
Email
in****@****trx.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
PRINCETON, New Jersey
Looking for a particular Oyster Point Pharma employee's phone or email?

Oyster Point Pharma Questions

News

Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris - GlobeNewswire

Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris GlobeNewswire

Oyster Point Pharma’s TYRVAYA™ (varenicline solution) Nasal Spray is Now Available at U.S. Regional Wholesalers for Distribution to Pharmacies for the Treatment of the Signs and Symptoms of Dry Eye Disease - Yahoo Finance

Oyster Point Pharma’s TYRVAYA™ (varenicline solution) Nasal Spray is Now Available at U.S. Regional Wholesalers for Distribution to Pharmacies for the Treatment of the Signs and Symptoms of Dry Eye Disease Yahoo Finance

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Oyster Point Pharma Provides Key Supply Chain Insight For OC-01 (varenicline) Nasal Spray - Yahoo Finance

Oyster Point Pharma Provides Key Supply Chain Insight For OC-01 (varenicline) Nasal Spray Yahoo Finance

Oyster Point Pharma Announces Pricing of Initial Public Offering - GlobeNewswire

Oyster Point Pharma Announces Pricing of Initial Public Offering GlobeNewswire

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights - GlobeNewswire

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights GlobeNewswire

Oyster Point Pharma Submits a Phase 2 Clinical Trial - GlobeNewswire

Oyster Point Pharma Submits a Phase 2 Clinical Trial GlobeNewswire

Oyster Point Pharma Announces Exclusive License Agreement - GlobeNewswire

Oyster Point Pharma Announces Exclusive License Agreement GlobeNewswire

Top Oyster Point Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant